Incidence of Early Complications Requiring Treatment Plan Changes After Vitreoretinal Surgery: a Single-center Study in South Korea

Overview

Journal BMC Ophthalmol

Publisher Biomed Central

Specialty Ophthalmology

Date 2023 Jun 18

PMID 37332012

Authors

Ji Hyun Yoon

Jae Hui Kim

Chul Gu Kim

Jong Woo Kim

Affiliations

Soon will be listed here.

Abstract

Background: Information regarding incidence of treatment plan changes may be useful when discussing postoperative treatment plans for patients. Moreover, it may help establish a standardized postoperative treatment plan. This study aimed to evaluate the incidence of early complications requiring treatment plan changes in patients following vitreoretinal surgery and investigate its risk factors.

Methods: This single-center retrospective study included 465 patients who had undergone vitreoretinal surgery. The reasons, incidence, and timing of treatment plan changes within 14 days of surgery were identified. Potential factors associated with the changes, such as patient demographics, surgeon's experience, diagnoses, and type of surgery were also analyzed.

Results: The treatment plan was changed in 76 patients (16.3%) at a mean of 4.0 ± 3.2 days after vitreoretinal surgery. The reasons for the plan changes were increased intraocular pressure (IIOP) in 66(86.8%), intraocular inflammation in 2(2.6%), corneal edema in 3(3.9%), leakage from the sclerotomy wound in 3(3.9%) patients, and combined IIOP and intraocular inflammation in 2(2.6%). The date of discharge was postponed because of treatment plan changes in 17 patients (22.4%). The incidence of plan changes was higher in patients who underwent gas or oil tamponade (P < 0.001) and those who underwent surgery performed by less experienced surgeons (P = 0.034).

Conclusions: Treatment plan was changed in 16.3% of patients after vitreoretinal surgery. The risk of treatment plan changes was associated with the surgeon's experience in vitreoretinal surgery and the type of surgery. These results should be considered when establishing standardized care plans for patients who require vitreoretinal surgery.

References

Kanclerz P, Grzybowski A . Complications Associated with the Use of Expandable Gases in Vitrectomy. J Ophthalmol. 2018; 2018:8606494. PMC: 6276446. DOI: 10.1155/2018/8606494. View

Jabbour E, Azar G, Antoun J, Kourie H, Abdelmassih Y, Jalkh A . Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection. Ophthalmologica. 2018; 240(3):129-134. DOI: 10.1159/000489792. View

Mehta A, Goldstein S, Makary M . Global trends in center accreditation by the Joint Commission International: growing patient implications for international medical and surgical care. J Travel Med. 2017; 24(5). DOI: 10.1093/jtm/tax048. View

Radeck V, Helbig H, Barth T, Gamulescu M, Maerker D, Prahs P . The learning curve of retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol. 2021; 259(8):2167-2173. PMC: 8352825. DOI: 10.1007/s00417-021-05096-1. View

Dave V, Pathengay A, Basu S, Gupta N, Basu S, Raval V . Endophthalmitis After Pars Plana Vitrectomy: Clinical Features, Risk Factors, and Management Outcomes. Asia Pac J Ophthalmol (Phila). 2016; 5(3):192-5. DOI: 10.1097/APO.0000000000000192. View

Al-Hinai A . Corneal epithelial defect after pars plana vitrectomy. Oman J Ophthalmol. 2017; 10(3):162-166. PMC: 5657157. DOI: 10.4103/ojo.OJO_122_2016. View

Znaor L, Medic A, Binder S, Vucinovic A, Marin Lovric J, Puljak L . Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments. Cochrane Database Syst Rev. 2019; 3:CD009562. PMC: 6407688. DOI: 10.1002/14651858.CD009562.pub2. View

Glassman A, Beaulieu W, Maguire M, Antoszyk A, Chow C, Elman M . Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021; 139(7):725-733. PMC: 8295737. DOI: 10.1001/jamaophthalmol.2021.1110. View

Yamakiri K, Sakamoto T, Koriyama C, Kawasaki R, Baba T, Nishitsuka K . Effect of surgeon-related factors on outcome of retinal detachment surgery: analyses of data in Japan-retinal detachment registry. Sci Rep. 2022; 12(1):4213. PMC: 8913601. DOI: 10.1038/s41598-022-07838-5. View

10.

Gupta O, Ho A, Kaiser P, Regillo C, Chen S, Dyer D . Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2008; 146(2):193-197. DOI: 10.1016/j.ajo.2008.04.010. View

11.

Mazinani B, Rajendram A, Walter P, Roessler G . Does surgical experience have an effect on the success of retinal detachment surgery?. Retina. 2011; 32(1):32-7. DOI: 10.1097/IAE.0B013E3182411CD2. View

12.

Fujii G, de Juan Jr E, Humayun M, Chang T, Pieramici D, Barnes A . Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002; 109(10):1814-20. DOI: 10.1016/s0161-6420(02)01119-3. View

13.

Desai A, Rubinstein A, Reginald A, Parulekar M, Tanner V . Feasibility of day-case vitreoretinal surgery. Eye (Lond). 2006; 22(2):169-72. DOI: 10.1038/sj.eye.6702515. View

14.

Patel D, Borkar D, Madhava M, Obeid A, Mellen P, Regillo C . Incidence of Management Changes at the Postoperative Day One Visit After Pars Plana Vitrectomy for Retinal Detachment. Am J Ophthalmol. 2020; 222:271-276. PMC: 7521411. DOI: 10.1016/j.ajo.2020.09.034. View

15.

Bamonte G, Mura M, Tan H . Hypotony after 25-gauge vitrectomy. Am J Ophthalmol. 2010; 151(1):156-60. DOI: 10.1016/j.ajo.2010.06.042. View

16.

Rizzo S, Belting C, Genovesi-Ebert F, Di Bartolo E . Incidence of retinal detachment after small-incision, sutureless pars plana vitrectomy compared with conventional 20-gauge vitrectomy in macular hole and epiretinal membrane surgery. Retina. 2010; 30(7):1065-71. DOI: 10.1097/IAE.0b013e3181cd48b0. View

17.

Yorgun M, Toklu Y, Mutlu M, Ozen U . Clinical outcomes of 25-gauge vitrectomy surgery for vitreoretinal diseases: comparison of vitrectomy alone and phaco-vitrectomy. Int J Ophthalmol. 2016; 9(8):1163-9. PMC: 4990582. DOI: 10.18240/ijo.2016.08.13. View

18.

Chen H, Yeung L, Yang K, Sun C . PERSISTENT CORNEAL EPITHELIAL DEFECT AFTER PARS PLANA VITRECTOMY. Retina. 2015; 36(1):148-55. DOI: 10.1097/IAE.0000000000000657. View

19.

Mehraban Far P, Yeung S, Ma P, Hurley B, Kertes P, You Y . Effects of Internal Limiting Membrane Peel for Idiopathic Epiretinal Membrane Surgery: A Systematic Review of Randomized Controlled Trials. Am J Ophthalmol. 2021; 231:79-87. DOI: 10.1016/j.ajo.2021.04.028. View

20.

Elhusseiny A, Schwartz S, Flynn Jr H, Smiddy W . Long-Term Outcomes after Macular Hole Surgery. Ophthalmol Retina. 2019; 4(4):369-376. DOI: 10.1016/j.oret.2019.09.015. View